Brief: Sienna Biopharmaceuticals reports Q2 loss of $6.50/shr
07/09/2017 13:05
Sept 7 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O
* Sienna Biopharmaceuticals reports second quarter 2017
financial results
* Qtrly loss per share $6.50
Source text for Eikon: ID:nGNXOEBXRa
Further company coverage: SNNA.O
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures